Episodes

Ellis Martin speaks with Dr. Brad Thompson of Oncolytics Biotech (ONCY) about both preventing cancer and treating it through Reolysin therapy. Patrick Yoder of Nobilis Health (HLTH) discusses successful sales strategies. In a new travel segment, Ellis chats with Amanda LeVett of the Carmel Boutique Inns, offering four pet friendly 5-star resort lodges and Inns in picturesque Carmel by the Sea along California's Central Coast.

After a recent trip Ellis Martin rants and raves about the delicious food everywhere in Greece and not so much anywhere in the US. Opinion Editor Bob Lange rants about the state of Healh Care in the US. Dr. Brad Thompson of Oncolytics Biotech (ONCY) discusses the benefits of treating cancer with the company's proprietary Reolysin technology using viruses that fight the tumors only...and Nobilis Health's (HLTH) exceptional marketing efforts brings boutique pain related surgical centers successful...

In this episode, Ellis chats with comedian, author and journalist Susan McIntosh about unimportant social issues that dramatically affect our culture. Dr. Brad Thompson of Oncolytics Biotech (ONCY) updates our audience about the successes in fighting cancer. Nobilis Health's Ken Effird talks profitability in business development and Bob Lange chats about the new frontier.

In this episode, Dr. Brad Thompson returns to discuss success in the field of oncology, fighting cancer tumors with proprietary Reolysin technology with 1100 patients treated to date via his company Oncolytics Biotech (SHGT) Ken Efird with Nobilis Health Corp (HLTH) discusses the methodology behind business develop and dramatically increased revenues for the company through marketing and patient service with the company's boutique surgical centers throughout the country. David Morgan chats with ...

Join Ellis Martin for an interview with Kenneth Efird of Nobilis Health Corp, trading on the NYSE as HLTH and on the Toronto Stock Exchange as NHC. Nobilis owns and manages ambulatory and acute care facilities to deliver healthcare services. Their focus is improving access to care and patient outcomes by providing minimally invasive procedures that can be performed in low-cost, outpatient settings. They utilize innovative direct-to-patient marketing and proprietary technologies to drive patient ...

In this episode David Morgan of The Morgan Report says these are the good old days and we've reached a standard of living top that must come down. Bob Lange opines on Steven Chen's company, Success Holding Group International (SHGT). Brad Thompson of Oncolytics Biotech discusses a virus that kills cancers cells and Ellis Martin rants about the recent China bubble US stock market reset.

In this episode David Morgan of The Morgan Report says these are the good old days and we've reached a standard of living top that must come down. Bob Lange opines on Steven Chen's company, Success Holding Group International (SHGT). Brad Thompson of Oncolytics Biotech discusses a virus that kills cancers cells and Ellis Martin rants about the recent China bubble US stock market reset.

On this week’s program Ellis Martin speaks with Micheal Skerry, an investor with Success Holding Group International, trading on the OTCQB under the symbol SHGT. SHGT is founded by Steve Chen, Asia’s number one motivational speaker with over 85 million followers generating over$ 60 million in gross revenues alone yearly. SHGT has a health drink called 888 which by the end of this year is purported to be in 50,000 convenience stores across China. Bob Lange offers his opinion on investing in SHGT ...

On this week’s program Ellis speaks with Micheal Skerry, an investor with Success Holding Group International, trading on the OTCQB under the symbol SHGT. SHGT is founded by Steve Chen, Asia’s number one motivational speaker with over 85 million followers generating over$ 60 million in gross revenues alone yearly. SHGT has a health drink called 888 which by the end of this year is purported to be in 50,000 convenience stores across China,. He’ll also talk with Brad Thompson, the president of Onc...

In this episode of The Ellis Martin report David Morgan reveals a new technology to portably mill gold on a mine site freeing up potential cash. Dudley Baker and Ellis Martin spar about the viability of $900-$1000/ounce gold and investor Micheal Skerry discusses why he is a firm believer in Success Holding Group International (SHGT) and why he believes it's a potentially rewarding investment opportunity.

In this episode join Ellis for a look at Success Holding trading as SHGT on the OTCBB and their founder Steve Chen, Asia's top motivational speaker with over 80 million followers. Dr. Brad Thompson of Oncolytics Biotech (ONCY) chats about cancer remediation and their proprietary Reolysin technology. Ellis decides to claim his trophy as the only one who called $900 dollar gold 18 months ago. Listen to his rant and why we’re on our way to it.

In this episode join Ellis for a look at Success Holding trading as SHGT on the OTCBB and their founder Steve Chen, Asia's top motivational speaker with over 80 million followers. Dr. Brad Thompson of Oncolytics Biotech (ONCY) chats about cancer remediation and their proprietary Reolysin technology. Ross Orr of Bactech Environmental (BCCEF) re-introduces our audience to a company that cleans up harmful mining tailings and turns them into profit. David Morgan discusses commodities and precious me...

In this episode of The Ellis Martin Report, join Ellis for a conversation with TheRavingCapitalist.com. Paul Mladjenovic. He’s concerned about world economic woes and he’s cautioning us about the next few months. Dudley Baker of CommonstockWarrants.com and Ellis traveled to Las Vegas and back and all they brought back was a conversation about resource stocks. And Ellis speaks with Dr. Brad Thompson of Oncolytics Biotech trading in the US as ONCY about remediating brain cancer in children. Oncoly...

Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers including today’s topic, pediatric cancer. Author, columnist and Ellis’ mentor Ron Irwin chats about his latest two books, one about life after his own death, the other about Hollywood Stage.. and David Morgan of www.TheMorganReport.com joins us to speak about the s...

Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers including today’s topic, pediatric cancer. Author, columnist and Ellis’ mentor Ron Irwin chats about his latest two books, one about life after his own death, the other about Hollywood Stage.. and David Morgan of www.TheMorganReport.com joins us to speak about the s...

Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers including today’s topic, pediatric cancer. Author, columnist and Ellis’ mentor Ron Irwin chats about his latest two books, one about life after his own death, the other about Hollywood Stage.. and David Morgan of www.TheMorganReport.com joins us to speak about the d...

Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers including today’s topic, pediatric cancer. Ross Orr, of Bactech Environmental (OTC:BCCEF/CSE:BAC) joins us. BacTech is a pioneering, environmental technology company that has developed and commercialized a proprietary technology to remediate highly toxic tailing are...

Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers including today’s topic, pediatric cancer. Ross Orr, of Bactech Environmental (OTC:BCCEF/CSE:BAC) joins us. BacTech is a pioneering, environmental technology company that has developed and commercialized a proprietary technology to remediate highly toxic tailing are...

Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll chat with Harry Fleming, Executive Chairman of Texas based Nobilis Health Trading on the NYSE as HLTH. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. Ross Orr, President of Bactech Environ...

Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll chat with Harry Fleming, Executive Chairman of Texas based Nobilis Health Trading on the NYSE as HLTH. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. Ross Orr, President of Bactech Environ...

On this program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll then chat with Harry Fleming, the President of Texas based Nobilis Health Trading on the TSX as NHC. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. We’ve seen their share price ne...

Today on the program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll then chat with Harry Fleming, the President of Texas based Nobilis Health Trading on the TSX as NHC. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. We’ve seen their share pri...

In this episode Ellis speaks with Greg Johnson, CEO of Wellgreen Platinum (TSX:WG) about the Wellgreen PGM Project in the Canadian Yukon Territory. Ellis then chats with several of the principles of Nobilis Health based in Houston and Dallas, Texas as well as Phoenix with boutique surgical centers throughout their service areas and a recent share price double since January of 2015.